SEATTLE — Patients who initiate ART without pretherapy CD4 monitoring experience a higher risk for early mortality than those who are tested, study data presented at CROI suggest. “We think that it’s ...

A new point-of-care test to measure CD4 T-cells, the prime indicator of HIV disease progression, can expedite the process leading from HIV diagnosis to antiretroviral therapy (ART) and improve ...

A new CD4 testing system, the BD FACSPresto Near Patient CD4 Counter system (BD Biosciences), enables patients to monitor their HIV/AIDS, potentially reducing the probability of transmitting the ...

Checking CD4 helper T cell levels up to 4 times a year has been a mainstay of HIV/AIDS monitoring, but the value of the test has diminished as the ability to directly detect viral RNA has improved and ...

Research in Mozambique has found that the introduction of rapid point-of-care CD4 testing* almost halved the number of patients who dropped out before starting antiretroviral therapy (ART), and nearly ...

February 20, 2010 (San Francisco, California) — Viral load monitoring is significantly superior to CD4 monitoring in assessing viral suppression and treatment failure for HIV patients on ...

A practical resource-based public health approach for the rapid initiation of antiretroviral therapy in HIV-infected individuals living in low- and middle-income countries could save thousands of ...

Global AIDS experts say “in these economic times” they’re looking for ways to get more HIV positive people into treatment using the money and resources they already have. Local researchers who say ...

Routine use of point-of-care CD4 testing at the time of HIV diagnosis would be cost effective in countries where health care and other resources are severely limited, experts say. A new point-of-care ...

A new point-of-care test to measure CD4 T-cells, the prime indicator of HIV disease progression, can expedite the process leading from HIV diagnosis to antiretroviral therapy (ART) and improve ...